Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Cash Flow Quality Index
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Cash Flow Quality Index of -0.28x as of December 2021. Operating cash flow of $-1.22 Million is below net income of $4.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore LIMN total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Liminatus Pharma, Inc. Class A Common Stock Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Liminatus Pharma, Inc. Class A Common St to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock (2021–2021)
Year-by-year earnings quality comparison for Liminatus Pharma, Inc. Class A Common Stock. For live market cap and the full company financial profile, see Liminatus Pharma, Inc. Class A Common St market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.28x | $-1.22 Million | $4.37 Million | — |